Autoimmune pancreatitis and complement activation system.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 16340739)

Published in Pancreas on January 01, 2006

Authors

Takashi Muraki1, Hideaki Hamano, Yasuhide Ochi, Kenichi Komatsu, Yuichi Komiyama, Norikazu Arakura, Kaname Yoshizawa, Masao Ota, Shigeyuki Kawa, Kendo Kiyosawa

Author Affiliations

1: Department of Medicine and Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.

Articles citing this

Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95

Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan. Int J Rheumatol (2012) 1.56

IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol (2015) 1.22

Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis. J Gastroenterol (2008) 1.18

IgG4-related kidney disease--an update. Curr Opin Nephrol Hypertens (2015) 1.11

Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10

Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol (2007) 1.04

Immunology of IgG4-related disease. Clin Exp Immunol (2015) 1.00

IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol (2014) 0.98

Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol (2011) 0.98

A novel immunoglobulin-immunoglobulin interaction in autoimmunity. PLoS One (2008) 0.96

Recent advances in the concept and pathogenesis of IgG4-related disease in the hepato-bilio-pancreatic system. Gut Liver (2014) 0.92

Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol (2012) 0.90

Hypocomplementemia of unknown etiology: an opportunity to find cases of IgG4-positive multi-organ lymphoproliferative syndrome. Rheumatol Int (2009) 0.88

Autoimmune pancreatitis--a new evolving pancreatic disease? Langenbecks Arch Surg (2010) 0.88

Autoimmune pancreatitis can develop into chronic pancreatitis. Orphanet J Rare Dis (2014) 0.84

Commensal Flora, is it an Unwelcomed Companion as a Triggering Factor of Autoimmune Pancreatitis? Front Physiol (2012) 0.84

A case of IgG4-related tubulointerstitial nephritis concurrent with Henoch-Schönlein purpura nephritis. Allergy Asthma Clin Immunol (2011) 0.83

Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J Gastroenterol (2009) 0.80

Acute recurrent pancreatitis: an autoimmune disease? World J Gastroenterol (2008) 0.78

Types of Organ Involvement in Patients with Immunoglobulin G4-related Disease. Chin Med J (Engl) (2016) 0.78

Immune Complex-Mediated Complement Activation in a Patient with IgG4-Related Tubulointerstitial Nephritis. Case Rep Nephrol Urol (2011) 0.77

Are dysregulated inflammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis. ISRN Gastroenterol (2011) 0.77

Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodies. BMC Immunol (2013) 0.76

The proteome of postsurgical pancreatic juice. Pancreas (2015) 0.76

Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75

Autoimmune pancreatitis. Gland Surg (2016) 0.75

Autoimmune pancreatitis: pathogenesis, latest developments and clinical guidance. Ther Adv Chronic Dis (2014) 0.75

Complement in Pancreatic Disease-Perpetrator or Savior? Front Immunol (2017) 0.75

Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland. PLoS One (2016) 0.75

Articles by these authors

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39

Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents. J Med Chem (2002) 7.27

International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26

Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology (2008) 2.70

Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet (2002) 2.69

Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol (2007) 2.60

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology (2004) 2.40

Hepatocellular carcinoma: recent trends in Japan. Gastroenterology (2004) 2.35

Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol (2008) 2.31

Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25

Operative morbidity of living liver donors in Japan. Lancet (2003) 2.13

Japanese clinical guidelines for autoimmune pancreatitis. Pancreas (2009) 2.11

Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy. J Gastroenterol Hepatol (2002) 2.07

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer (2004) 2.03

Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation (2002) 2.01

Mechanisms of lower bile duct stricture in autoimmune pancreatitis. Pancreas (2014) 1.98

HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology (2002) 1.92

Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc (2005) 1.81

Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci (2012) 1.72

Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol (2008) 1.67

Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. Helicobacter (2002) 1.65

PPARalpha protects proximal tubular cells from acute fatty acid toxicity. J Am Soc Nephrol (2007) 1.62

Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60

Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology (2007) 1.58

A case of Mikulicz's disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med (2012) 1.56

Leptin and leptin receptor gene polymorphisms in obstructive sleep apnea syndrome. Chest (2007) 1.55

PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest (2008) 1.55

Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis (2009) 1.55

A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome. Intern Med (2010) 1.54

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. Hepatol Res (2005) 1.51

ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc (2002) 1.47

Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol (2009) 1.47

Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study. J Gastroenterol (2007) 1.45

Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol (2009) 1.44

Idiopathic myelofibrosis with refractory massive ascites. Intern Med (2003) 1.43

Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci (2008) 1.43

Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography. Dig Endosc (2012) 1.41

Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity. Genetics (2006) 1.37

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol (2008) 1.33

Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol (2004) 1.32

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32

Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology (2010) 1.28

IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med (2006) 1.28

Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas (2006) 1.26

Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol (2014) 1.26

Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis (2008) 1.25

Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol (2002) 1.18

Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis (2003) 1.18

The COL1A1 gene and high myopia susceptibility in Japanese. Hum Genet (2007) 1.17

Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress. J Hepatol (2009) 1.16

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol (2007) 1.16

Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation (2005) 1.16

Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant (2003) 1.12

Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet (2002) 1.11

Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10

High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci (2005) 1.10